Protagenic Therapeutics (NASDAQ:PTIX) Releases Quarterly Earnings Results

Protagenic Therapeutics (NASDAQ:PTIX) posted its quarterly earnings data on Monday. The company reported ($0.24) earnings per share (EPS) for the quarter, Zacks reports.

Protagenic Therapeutics Trading Down 10.2 %

Shares of Protagenic Therapeutics stock traded down $0.02 on Monday, hitting $0.20. 113,731 shares of the company traded hands, compared to its average volume of 636,276. The company has a market cap of $1.46 million, a PE ratio of -0.16 and a beta of 0.43. The stock’s 50 day moving average price is $0.31 and its 200-day moving average price is $0.49. Protagenic Therapeutics has a 52 week low of $0.19 and a 52 week high of $1.87.

About Protagenic Therapeutics

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.